Ignite Creation Date:
2025-12-24 @ 2:50 PM
Ignite Modification Date:
2026-04-24 @ 5:07 AM
Study NCT ID:
NCT02539459
Status:
TERMINATED
Last Update Posted:
2022-12-15
First Post:
2015-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus
Sponsor:
Fox Chase Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-20
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-20
First Submit QC Date:
None
Study First Post Date:
2015-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-01-27
Results First Submit QC Date:
None
Results First Post Date:
2021-02-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-13
Last Update Post Date:
2022-12-15
Last Update Post Date Type:
ACTUAL